Extended spectrum beta lactamases (ESBLs) are enzymes that mediate resistance to extended-spectrum or third generation cephalosporins like ceftazidime, cefotaxime, and ceftriaxone and monobactams like aztreonam. ESBLs do not affect cephamycins like cefoxitin and cefotetan or carbapenems like meropenem or imipenem.

1. Pharmacology – MCQ 80 – Antibacterial agents inhibiting cell wall synthesis
2. Pharmacology – MCQ 84 – Antibiotic for MRSA
3. DRACO – the novel broad spectrum antiviral
4. Amoxycillin and clavulanic acid (Co-amoxyclav)